Thursday, May 19, 2022 11:21:17 AM
Thanks Reefrad for your feedback. I don't agree w DI that not updating CT.gov was a nothing burger. A couple of negative articles and tweets changed the narrative of the NTAS presentation. And I'm guessing we may or may not get ASCO prolly depending on whether the Journal article comes out? And I was kind of hoping we'd get a LBA reveal on May 27th even though there were good arguments that since MB was presenting at the ASCO IET a LBA wouldn't happen.
The good news I get from your discussion is that multiple pieces of good news could happen i.e Journal article, Sawston update, and perhaps BLA/MA movement.
For me the biggie is getting news on the MHRA front and perhaps Breakthrough Therapy Designation from the FDA. BTD can happen a couple of months after submitting their TLD along with other Data to the Agency. Who knows they could have had that BTD meeting awhile back since they had internal TLD in their pocket for a while and we could get a PR any day now about it. That's what I hope happens but not to confident that it will...until it happens :)
The good news I get from your discussion is that multiple pieces of good news could happen i.e Journal article, Sawston update, and perhaps BLA/MA movement.
For me the biggie is getting news on the MHRA front and perhaps Breakthrough Therapy Designation from the FDA. BTD can happen a couple of months after submitting their TLD along with other Data to the Agency. Who knows they could have had that BTD meeting awhile back since they had internal TLD in their pocket for a while and we could get a PR any day now about it. That's what I hope happens but not to confident that it will...until it happens :)
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
